Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells

Type I and II topoisomerase activities were partially purified from Pneumocystis carinii. The catalytic (strand-passing) activities of both enzymes were selectively inhibited by members of a series of dicationic-substituted bis-benzimidazoles compared with those of topoisomerases of mammalian (calf thymus) origin. The most active inhibitors of the parasite enzymes were also highly effective in an in vivo animal model of P. carinii pneumonia. Selected dicationic-substituted bis-benzimidazoles also strongly inhibited the induction of the topoisomerase I- and II-mediated cleavable complex, suggesting that the biologically active DNA minor groove-binding molecules inhibit the enzyme-DNA binding step of the topoisomerase reaction sequence. The apparent selectivities for the parasite enzymes and the low levels of toxicity to mammalian cells for the biologically active bis-benzimidazoles suggest that these compounds hold promise as effective therapeutic agents in the treatment of a life-threatening AIDS-related disease, P. carinii pneumonia.

[1]  C. Dykstra,et al.  Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition , 1993, Antimicrobial Agents and Chemotherapy.

[2]  B. Gatto,et al.  DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Borst,et al.  Kinetoplast DNA , 1993, Current Biology.

[4]  J. Hall,et al.  Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia , 1993, Antimicrobial Agents and Chemotherapy.

[5]  R. Tidwell,et al.  Structure, DNA minor groove binding, and base pair specificity of alkyl- and aryl-linked bis(amidinobenzimidazoles) and bis(amidinoindoles). , 1993, Journal of medicinal chemistry.

[6]  J. Alsner,et al.  Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events. , 1992, Journal of molecular biology.

[7]  Y. Bathini,et al.  Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. , 1992, Biochimica et biophysica acta.

[8]  U. K. Laemmli,et al.  In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. , 1992, The EMBO journal.

[9]  A. Amadei,et al.  The conformation of constitutive DNA interaction sites for eukaryotic DNA topoisomerase I on intrinsically curved DNAs. , 1991, Biochimica et biophysica acta.

[10]  K. Kohn,et al.  Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide. , 1991, Nucleic acids research.

[11]  C. Dykstra,et al.  Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. , 1991, The Journal of protozoology.

[12]  T. Andoh,et al.  Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives. , 1991, Cancer research.

[13]  J. Hall,et al.  Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures , 1991, Antimicrobial Agents and Chemotherapy.

[14]  J. Lown,,et al.  Netropsin and bis-netropsin analogs as inhibitors of the catalytic activity of mammalian DNA topoisomerase II and topoisomerase cleavable complexes. , 1991, Biochimica et biophysica acta.

[15]  J. Hall,et al.  Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines , 1991, Antimicrobial Agents and Chemotherapy.

[16]  J. Hall,et al.  Structure-activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity , 1991, Antimicrobial Agents and Chemotherapy.

[17]  U. Mortensen,et al.  Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature. , 1991, Nucleic acids research.

[18]  D. Kyle,et al.  Structure-activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis , 1990, Antimicrobial Agents and Chemotherapy.

[19]  M. McHugh,et al.  Effect of minor groove binding drugs on mammalian topoisomerase I activity. , 1989, Biochemical pharmacology.

[20]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[21]  T. Beerman,et al.  DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. , 1989, Biochemistry.

[22]  W. Kohlbrenner,et al.  Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. , 1989, The Journal of biological chemistry.

[23]  L. Bolund,et al.  Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage. , 1988, Journal of molecular biology.

[24]  M Linial,et al.  Sequence-directed bent DNA helix is the specific binding site for Crithidia fasciculata nicking enzyme. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Besterman,et al.  Amiloride intercalates into DNA and inhibits DNA topoisomerase II. , 1987, The Journal of biological chemistry.

[26]  M. Waring,et al.  Comparison of binding sites in DNA for berenil, netropsin and distamycin. A footprinting study. , 1987, European journal of biochemistry.

[27]  D. Crothers,et al.  Effect of drug-DNA interactions upon transcription initiation at the lac promoter. , 1987, Biochemistry.

[28]  D. Auble,et al.  Specific activation of transcription initiation by the sequence-specific DNA-binding agents distamycin A and netropsin. , 1987, Biochemistry.

[29]  G. Kupfer,et al.  Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. , 1985, Biochemical pharmacology.

[30]  Peter B. Dervan,et al.  Molecular recognition of B-DNA by Hoechst 33258 , 1985, Nucleic Acids Res..

[31]  M. Waring,et al.  DNA structural variations produced by actinomycin and distamycin as revealed by DNAase I footprinting. , 1984, Nucleic acids research.

[32]  L. Liu,et al.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Liu,et al.  Cleavage of DNA by mammalian DNA topoisomerase II. , 1983, The Journal of biological chemistry.

[34]  J. Vournakis,et al.  Sequence specificity of actinomycin D and Netropsin binding to pBR322 DNA analyzed by protection from DNase I. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Dubovi,et al.  Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin. , 1983, Journal of medicinal chemistry.

[36]  P. T. Englund,et al.  Decatenation of kinetoplast DNA by topoisomerases. , 1980, The Journal of biological chemistry.

[37]  E. Greenspan,et al.  THE PHARMACOLOGY, MODE OF ACTION AND THERAPEUTIC POTENTIALITIES OF STILBAMIDINE, PENTAMIDINE, PROPAMIDINE AND OTHER AROMATIC DIAMIDINES—A REVIEW , 1948, Medicine.

[38]  G. Riou,et al.  ATP‐independent DNA topoisomerase II as potential drug target in trypanosomes , 1988, Biology of the cell.

[39]  C Zimmer,et al.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. , 1986, Progress in biophysics and molecular biology.

[40]  L. Liu,et al.  Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. , 1984, The Journal of biological chemistry.